Aksu, Ahmet GoktanGunduz, OzgurUlugol, Ahmet2024-06-122024-06-1220180008-42121205-7541https://doi.org/10.1139/cjpp-2017-0567https://hdl.handle.net/20.500.14551/18577The antinociceptive effects of cannabinoids and opioids have been known for centuries. Serotonin and its receptors are also known to play important roles in nociception. However, the contribution of spinal 5-HT5A receptors in antinociceptive effects of cannabinoids and opioids has not been studied. We conducted this study to clarify spinal mechanisms of the actions of the antinociceptive effects of cannabinoids and opioids. Hot plate and tail fl(i)ck tests were used to assess the antinociceptive activity in Balb/c mice. WIN 55,212-2, a nonselective CB1 and CB2 agonist, and morphine exerted significant antinociceptive effects at 1, 3, and 10 mg/kg doses administered intraperitoneally in both hot plate and tail flick tests. The selective 5-HT5A receptor antagonist SB-699551 (10 nmol/mouse) was administered intrathecally 10 min before the agonists. SB-699551 significantly reduced the antinociceptive effect of both WIN 55,212-2 and morphine. In the rotarod test, WIN 55,212-2 disrupted the motor coordination at a dose of 10 mg/kg, while morphine did not affect this function at any dose. Our findings show that spinal 5-HT5A receptors are involved in the antinociceptive effects of WIN 55,212-2 and morphine.en10.1139/cjpp-2017-0567info:eu-repo/semantics/closedAccessAntinociceptionMorphineSB-699551Spinal 5-HT5A ReceptorsWIN 55,212-2Neuropathic PainNoradrenergic SystemsTherapeutic TargetNerve InjuryRat ModelSerotoninCordInvolvementAnalgesiaPathwaysArticle966618623Q3WOS:0004340450000112-s2.0-8504817343329406831Q3